Privium Fund Management B.V. Invests $1.24 Million in Cartesian Therapeutics, Inc. $RNAC
MarketBeat
Privium Fund Management B.V. acquired a new position in shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 172,500 shares of the company's stock, valued
NASDAQ:RNAC